Benlysta IV infusion 120mg, manufactured by GlaxoSmithKline, contains Belimumab (genetical recombination) (YJ code: 3999445D1020, 120mg 1 bottle). This B-lymphocyte stimulator (BLyS)-specific inhibitor treats active systemic lupus erythematosus (SLE) and active lupus nephritis in adults.
Benlysta IV infusion 120mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →